Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 23(14)2022 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-35887267

RESUMEN

This study was performed to investigate the immune enhancement effect of glycine nano-selenium, a microelement on H9N2 avian influenza virus vaccine (H9N2 AIV vaccine) in mice. Fifty (50) Specific Pathogen Free Kunming mice aged 4−6 weeks (18−20 g Body weight) were randomly divided into five groups: control normal group, which received no immunization + 0.5 mL 0.9% normal saline, positive control group, which received H9N2 AIV vaccine + 0.5 mL 0.9% normal saline, 0.25 mg/kg selenium group, which received H9N2 AIV vaccine + 0.5 mL 0.25 mg/kg selenium solution, 0.5 mg/kg selenium group, which received H9N2 AIV vaccine + 0.5 mL 0.5 mg/kg selenium solution, and 1 mg/kg selenium group, which received H9N2 AIV vaccine + 0.5 mL 1 mg/kg selenium solution. Hematoxylin and eosin staining, enzyme linked immunosorbent assay (ELISA), and quantitative real time polymerase chain reaction (qRT-PCR) methods were used to investigate the pathological changes, immunoglobulin levels, and cytokine gene expressions in this study. The results showed that all tested doses (0.25 mg/kg, 0.5 mg/kg and 1.00 mg/kg) of glycine nano-selenium did not lead to poisoning in mice. In addition, when compared to the positive control group, glycine nano-selenium increased the immunoglobin indexes (IgA, IgG, IgM and AIV-H9 IgG in serum) as well as the mRNA levels of IL-1ß, IL-6 and INF-γ in the liver, lungs, and spleen (p < 0.05). In summary, glycine nano-selenium could enhance the efficacy of avian influenza vaccine.


Asunto(s)
Subtipo H9N2 del Virus de la Influenza A , Vacunas contra la Influenza , Gripe Aviar , Selenio , Animales , Pollos/genética , Citocinas/genética , Expresión Génica , Glicina/genética , Glicina/farmacología , Inmunoglobulina G/genética , Subtipo H9N2 del Virus de la Influenza A/genética , Ratones , Solución Salina , Selenio/farmacología
2.
J Drug Target ; 24(5): 433-40, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26422582

RESUMEN

10-Hydroxycamptothecin (HCPT) is a clinical therapy agent against hepatoma. The chemotherapy of HCPT is strongly obstructed by the emergence of multidrug resistance (MDR), serious systemic toxicity, malfunction of rapid phagocytic and renal clearance disorder which are undesirable for its chemotherapy. In this paper, a drug delivery system (DDS) for HCPT has been developed in order to overcome MDR. Nanostructured lipid carriers (NLC) coated with xyloglucan (XG) was prepared by soya oil and XG consisting of side chains with galactose residues, a terminal moiety that can be used to target HCPT to hepatoma. The therapeutic potential of XG-NLC/HCPT was investigated on HepG2/HCPT cells and on human tumor xenograft nude mouse model (implanted with HepG2/HCPT cells). XG-NLC/HCPT not only indicated superior cytotoxicity against the drug resistant HepG2 cells but also in vivo, generated a higher therapeutic effect. Systemic toxicity study demonstrated that the carrier reduced systemic toxicity. XG-NLC/HCPT proved a great potential to serve as DDS to overcome MDR of HepG2/HCPT cells. These results suggested that XG NLC/HCPT represent a promising carrier for drug delivery to the hepatoma and reverse the drug resistant of HepG2 cells and XG could be exploited as a potential targeting device for liver tissue.


Asunto(s)
Camptotecina/análogos & derivados , Portadores de Fármacos/química , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Lípidos/química , Nanoestructuras/química , Animales , Antineoplásicos Fitogénicos/farmacología , Camptotecina/química , Camptotecina/farmacología , Carcinoma Hepatocelular/tratamiento farmacológico , Línea Celular Tumoral , Portadores de Fármacos/administración & dosificación , Sistemas de Liberación de Medicamentos/métodos , Glucanos/química , Células Hep G2 , Humanos , Lípidos/administración & dosificación , Neoplasias Hepáticas/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Nanoestructuras/administración & dosificación , Tamaño de la Partícula , Aceite de Soja/química , Xilanos/química
3.
BMC Immunol ; 10: 55, 2009 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-19852827

RESUMEN

BACKGROUND: Susceptibility or resistance to infection with Listeria monocytogenes correlates with Selenium (Se) deficiency in response to infection. RESULTS: Se-deficient mouse models of listeriosis were used to study the innate immune response during the course of L. monocytogenes infection. Blood samples from mouse models were used for Se status. The concentration of MDA, SOD, GPx and CAT in blood has revealed that lower Se level exist in Se-deficient mice. Intestine, mesenteric lymph node, liver, spleen and brain from each mouse were to study the bacterial burden in organs. The analysis of cell types of spleen from Se-deficient mice revealed that the ability of the host to elicit a rapid recruitment and activation of systemic innate immune response to infection was to a certain extent compromised under conditions of Se deficiency. The cytokine levels in the serum and cytokine expression levels in the livers from Se-deficient mice revealed that the innate immune response of Se-deficient mice was impaired throughout the course of infection. These results suggest that innate immune response is altered by Se deficiency after infection with L. monocytogenes. CONCLUSION: In conclusion, induced susceptibility of host resistance is associated with an impaired innate immune response following infection with L. monocytogenes in C57BL/6 Se-deficient mice.


Asunto(s)
Citocinas/metabolismo , Sistema Inmunológico/inmunología , Listeria monocytogenes/inmunología , Listeriosis/inmunología , Selenio/inmunología , Animales , Recuento de Células , Células Cultivadas , Citocinas/sangre , Citocinas/genética , Citocinas/inmunología , Susceptibilidad a Enfermedades , Conducta Alimentaria , Femenino , Glutatión Peroxidasa/metabolismo , Sistema Inmunológico/metabolismo , Sistema Inmunológico/microbiología , Sistema Inmunológico/patología , Inmunidad Innata , Listeria monocytogenes/crecimiento & desarrollo , Listeria monocytogenes/patogenicidad , Listeriosis/sangre , Listeriosis/enzimología , Listeriosis/genética , Listeriosis/microbiología , Ratones , Ratones Endogámicos C57BL , Embarazo , Selenio/deficiencia , Selenio/metabolismo
4.
Eur J Pharm Sci ; 38(3): 215-23, 2009 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-19616097

RESUMEN

The development of novel antiviral drugs is necessary for the prevention and treatment of a potential avian influenza pandemic. The aim of this study was to evaluate the efficacy and safety of a novel statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in a murine model. In H5N1-, H3N2- and H1N1-infected BALB/c mice, 50mug statin/200mug caffeine effectively ameliorated lung damage and inhibited viral replication and was at least as effective as oseltamivir and ribavirin. The statin/caffeine combination also appeared to be more effective when administered preventatively rather than as treatment. These findings provide justification for further research into this novel antiviral formulation.


Asunto(s)
Cafeína/administración & dosificación , Inhibidores de Hidroximetilglutaril-CoA Reductasas/administración & dosificación , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Subtipo H3N2 del Virus de la Influenza A/efectos de los fármacos , Subtipo H5N1 del Virus de la Influenza A/efectos de los fármacos , Infecciones por Orthomyxoviridae/prevención & control , Animales , Cafeína/efectos adversos , Línea Celular , Pollos , Perros , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos/métodos , Femenino , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Subtipo H1N1 del Virus de la Influenza A/fisiología , Subtipo H3N2 del Virus de la Influenza A/fisiología , Subtipo H5N1 del Virus de la Influenza A/fisiología , Ratones , Ratones Endogámicos BALB C , Infecciones por Orthomyxoviridae/patología , Oseltamivir/efectos adversos , Oseltamivir/farmacología , Oseltamivir/uso terapéutico
5.
PLoS One ; 4(2): e4628, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19247447

RESUMEN

BACKGROUND: Susceptibility or resistance to infection with Cryptosporidium parvum (C.parvum) correlates with Selenium (Se) deficiency in response to infection. Both adult Se-adequate and Se-deficient mouse models of cryptosporidiosis were used to study the cell-mediated immune response during the course of C. parvum infection. METHODOLOGY/PRINCIPAL FINDINGS: Blood samples from mouse models were used for Se status. The concentration of MDA, SOD, GPx and CAT in blood has revealed that lower Se level exist in Se-deficient mice. Mesenteric lymph node (MLN) lymphocytes from both mouse models were proliferated after ex vivo re-stimulation with C. parvum sporozoite antigen. The study of the cytokine profiles from the supernatant of proliferated MLN cells revealed that Se-adequate mice produced higher levels of Th1 (IFN-gamma and IL-2) and moderate amounts of Th2 (IL-4) cytokines throughout the course of infection. Whereas, MLN cells from Se-deficient mice produced lower levels of IFN-gamma, IL-2 and IL-4 cytokines. The counts of total white cell and CD3, CD4, CD8 cell in Se-adequate were higher than that in Se-deficient mice. SIGNIFICANCE: These results suggest that Cell immunity is affected by Se status after infection with C. parvum from kinetic changes of different white cells and cytokine. In conclusion, induced susceptibility of host is associated with an impaired antioxidant system following infection with C. parvum in C57BL/6 Selenium deficient mice.


Asunto(s)
Antioxidantes/metabolismo , Criptosporidiosis/inmunología , Cryptosporidium parvum/aislamiento & purificación , Susceptibilidad a Enfermedades , Selenio/deficiencia , Animales , Antígenos CD/inmunología , Catalasa/sangre , Criptosporidiosis/parasitología , Citocinas/biosíntesis , Glutatión Peroxidasa/sangre , Inmunidad Celular , Recuento de Leucocitos , Malondialdehído/sangre , Ratones , Ratones Endogámicos C57BL , Superóxido Dismutasa/sangre
6.
Chin Med J (Engl) ; 122(23): 2893-7, 2009 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-20092797

RESUMEN

BACKGROUND: Neuropathic pain is induced by injury or disease of the nervous system. Most studies have so far focused only on a few known molecules and signaling pathways among neurons. However, all signal transmissions involved in neuropathic pain appear to be an integral system at different molecular levels. This study was designed to screen the differentially expressed genes of the hypothalamus in chronic constriction injury (CCI) rats and analyze their functions in developing neuropathic pain. METHODS: Ten adult female Sprague-Dawley rats ((200 +/- 10) g) were used in experimental group and sham group (n = 5 in each group). Mechanical allodynia tests were performed to ensure that the CCI rat model was constructed successfully. Total hypothalamus RNAs were isolated from each group. Forward suppression subtractive hybridization (SSH) library of rat hypothalamus was constructed and up-regulated cDNA clones at neuropathic pain states were obtained via suppressed subtractive hybridization technique and the functions of these genes were analyzed bioinformatically. RESULTS: Mechanical allodynia tests showed that the experimental rats had a significantly reduced mechanical allodynia threshold 3 to 13 days after CCI vs sham surgery rats (P < 0.01), indicating that the model was successful. Forward SSH library of the rat hypothalamus was constructed successfully and 26 over-expressed expression sequence tags (ESTs) were obtained from these up-regulated cDNA clones. CONCLUSION: Twenty-six up-regulated genes, involved in the regulation of cell cycle and apoptosis, signal transduction, and neuroprotection, may play key roles in decreasing mechanical withdraw thresholds in CCI rats, which implicates a multidimensional and integrated molecular mechanism at gene level in developing neuropathic pain with the supraspinal contributions.


Asunto(s)
Perfilación de la Expresión Génica , Hipotálamo/metabolismo , Dolor/metabolismo , Neuropatía Ciática/metabolismo , Animales , Biología Computacional , Modelos Animales de Enfermedad , Femenino , Óxido Nítrico/fisiología , Hibridación de Ácido Nucleico , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA